Guizhou Ruihe Pharmaceutical Co., Ltd. and Beijing Yingke Rui Innovation Pharmaceutical Co., Ltd. held a strategic cooperation signing ceremony.

On February 13, 2023, the signing ceremony of strategic cooperation between Guizhou Ruihe Pharmaceutical Co., Ltd. and Beijing Yingke Rui Innovation Pharmaceutical Co., Ltd. was held in the conference room of Guizhou Ruihe Pharmaceutical Co., Ltd.

Zhang Baoxian, founder and chairman of Beijing Yingke Rui Innovation Pharmaceutical Co., Ltd., Li Yanying, vice president, Huang Chaoqing, manager of the Achievement Transformation Center, Professor Zhang Liyan of Guizhou University of Traditional Chinese Medicine, Mr. Cha Jun of Guizhou University for Nationalities, Xiong Yigang, chairman of Guizhou Ruihe Pharmaceutical Co., Ltd., Zhao Yun, general manager, Zhang Yun, deputy general manager, and Chen Yuyou, secretary of the board of Guizhou Ruihe Pharmaceutical Co., attended the signing ceremony.

Beijing Yingkorui Innovation Pharmaceutical Co., Ltd. is an independent research and development-oriented, supplemented by research and development, new preparations are unique, and it integrates research and development, achievement transformation, and industrialization. It is in a leading position in the industry in the five major fields of traditional Chinese medicine compound new drugs, new preparations, innovative traditional Chinese medicine drugs, traditional Chinese medicine CRO and health food. Guizhou Ruihe Pharmaceutical Co., Ltd. has the strength and channels of product commercialization and industrialization. In this meeting, the two sides reached a cooperation intention and signed a strategic cooperation agreement.

Before the signing ceremony, Xiong Yigang, chairman of Guizhou Ruihe Pharmaceutical Co., Ltd., introduced in detail the company's development overview, development planning, product research and development, etc. Chairman Zhang Baoxian and Vice President Li Yanying of Beijing Yingke Rui Innovation Pharmaceutical Co., Ltd. also gave a detailed introduction to the development profile, talent team, R & D platform and R & D pipeline of Beijing Yingke Rui Innovation Pharmaceutical Co., Ltd. In addition, the leaders of all parties had in-depth exchanges on the current situation of the development of traditional Chinese medicine in China, the classic prescription of traditional Chinese medicine, and the development of preparations in traditional Chinese medicine hospitals. Professor Zhang and Professor Zhang also put forward valuable suggestions on the development direction of Ruihe Pharmaceutical.

The two sides jointly adhere to the principle of "equality and mutual benefit, mutual cooperation and common development", give full play to their respective advantages, expand cooperation areas and innovate cooperation models, with a view to jointly developing innovative drugs of traditional Chinese medicine and classic famous traditional Chinese medicine, and strive to achieve "win-win cooperation in science and innovation and production and research".

Finally, Mr. Xiong once again expressed his gratitude to Mr. Zhang, Professor Zhang and his party, and said that he would further strengthen the exchange and cooperation between enterprises, give full play to the advantages of both sides, and look forward to cooperating in the development of innovative drugs of traditional Chinese medicine, new preparations of traditional Chinese medicine, classic prescriptions of traditional Chinese medicine and large healthy varieties on the basis of strategic cooperation.